Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Income from Non-Controlling Interests (2017 - 2025)

BioCorRx's Income from Non-Controlling Interests history spans 7 years, with the latest figure at -$1.1 million for Q3 2025.

  • For Q3 2025, Income from Non-Controlling Interests changed N/A year-over-year to -$1.1 million; the TTM value through Sep 2025 reached -$3.8 million, changed N/A, while the annual FY2021 figure was -$5.3 million, 52.02% down from the prior year.
  • Income from Non-Controlling Interests for Q3 2025 was -$1.1 million at BioCorRx, down from -$16650.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at -$16650.0 in Q2 2024 and bottomed at -$1.6 million in Q1 2021.
  • The 3-year median for Income from Non-Controlling Interests is -$1.2 million (2021), against an average of -$1.1 million.
  • The largest YoY upside for Income from Non-Controlling Interests was 40.82% in 2021 against a maximum downside of 77.53% in 2021.
  • A 3-year view of Income from Non-Controlling Interests shows it stood at -$1.3 million in 2021, then skyrocketed by 98.69% to -$16650.0 in 2024, then crashed by 6562.89% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for BICX's Income from Non-Controlling Interests are -$1.1 million (Q3 2025), -$16650.0 (Q2 2024), and -$1.3 million (Q4 2021).